Regeneron Pharmaceuticals Inc REGN:NASDAQ

Last Price$629.51Cboe Real-Time Last Sale as of 11:23AM ET 7/13/20
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change+8.65(1.39%)
Bid (Size)$628.62 (100)
Ask (Size)$629.90 (97)
Day Low / High$619.00 - 630.67
Volume188.4 K
  • Latest Stories
  • Commentary and Analysis
Insider Trends: Insider at Regeneron Pharmaceuticals Exercises Options Derivative Securities, Sells for Taxes and Self, Selling Trend Unaffected
4:31PM ET 7/09/2020 MT Newswires

On Jul 07, 2020, EVP Finance CFO, Robert E Landry, exercised options/derivative securities for 12,500 shares. A portion of these optioned shares (11,340...

--Analyst Actions: SunTrust Robinson Humphrey Upgrades Regeneron Pharmaceuticals to Buy From Hold, Price Target $750 From $400
11:01AM ET 7/09/2020 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Analyst Actions: Canaccord Genuity Lifts Regeneron Pharmaceuticals PT to $700 From $660, Maintains Buy Rating
11:30AM ET 7/08/2020 MT Newswires

Regeneron Pharmaceuticals' (REGN) average rating among analysts is a buy, with an average price target of $560. (MT Newswires covers equity, commodity and...

Close Update: US Stocks End Near Day's Lows on Increasing COVID-19 Cases, Dim Outlook for Global Economic Recovery
4:30PM ET 7/07/2020 MT Newswires

US stocks closed near the day's lows as investors worried over news that about 40 states reportedly were seeing a rise in COVID-19 cases, threatening the...

Midday Report: US Stocks Mixed; COVID-19 Cases Mount as European Commission Warns of Bigger-Than-Forecast Contraction
1:19PM ET 7/07/2020 MT Newswires

US stocks were mixed amid subdued sentiment as about 40 states are said to have reported an increase in COVID-19 cases, threatening the rebound in growth,...

Stocks Press Pause on US Rally Amid Coronavirus Case Worries as Energy Shares Dent S&P 500
9:51AM ET 7/07/2020 MT Newswires

Stocks pulled lower on Tuesday as investors stepped back from the recent run of gains to press pause on the rally amid mounting COVID-19 cases that have...

Novavax Gets $1.6 Billion in US Funds for COVID-19 Vaccine While Regeneron Gets $450 Million Contract
8:49AM ET 7/07/2020 MT Newswires

Novavax (NVAX) was given $1.6 billion by the US government as it works to develop a vaccine against COVID-19, with the funding meant to include a clinical...

Regeneron Wins $450 Million US Contract to Supply COVID-19 Anti-Viral Cocktail
8:35AM ET 7/07/2020 MT Newswires

Regeneron Pharmaceuticals (REGN) said premarket Tuesday it has won a $450 million contract from the US government to manufacture and supply REGN-COV2, the...

Regeneron to Start Late-Stage Trial of COVID-19 Cocktail Treatment REGN-COV2 Amid Mounting Cases
1:57PM ET 7/06/2020 MT Newswires

Regeneron Pharmaceuticals (REGN) will begin late-stage clinical trials of a drug cocktail it's developing to treat COVID-19, a move that comes as infection...

Regeneron Pharmaceuticals Launches Phase 3 Trial of COVID-19 Antibody Treatment; Shares Rise
7:42AM ET 7/06/2020 MT Newswires

Regeneron Pharmaceuticals (REGN) said Monday it has initiated late-stage clinical trials evaluating REGN-COV2, the biotech company's investigational double...